Feb 20 (Reuters) - British drugmaker Indivior INDV.L
on Thursday projected a 17% decline in 2025 net revenue at the
midpoint of its forecast range, partly hurt by sluggish sales of
its film-form medication-assisted therapy for opiate addiction.
The company expects 2025 net revenue between $955 million
and $1.03 billion. It reported a 16% rise in adjusted operating
profit to $312 million for the year ended December 31, 2024.
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by
Subhranshu Sahu)
((abyjose.koilparambil@thomsonreuters.com;))